Akron-founded resilient titanium production outfit Precision Surface Science is sounding out potential angel investors as it looks to target industries including automotive, transport and medical devices.

Quell Therapeutics will develop treatments for conditions such as solid organ transplant rejection and has also secured capital from UCL Technology Fund.

UPMC-founded ID Connect offers a telemedicine platform to help hospitals manage the spread of serious infectious diseases.

DNA sequencing spinout Longas Technologies has been working away from public view since 2015, having secured cash from the Medical Research Commercialisation Fund as well as its own founding team and directors.

Keren Primor Cohen has been promoted to CEO of Tel Aviv University’s TTO as the successor to Shlomo Nimrodi, who has departed after seven years in the post.

University of Wyoming has spun out Wyomics to commercialise an ionic liquid product for extracting valuable materials including rare earth elements from coal and fly ash resources.

Regenerative medicine spinout LifeSprout is advancing JHU research into a nanofibre-fortified gel that can be injected to repair soft tissue.

Vay Sports has been spun out of University of Zurich to commercialise a fitness app that exploits computer vision to monitor a user's posture.

Needing to solve its debt predicament before the end of this year, Karolinska Development has launched negotiations with its largest convertible note holder, Sino Biopharmaceutical.

Tsinghua University has become the first Chinese mainland institution to top the Times Higher Education’s Asia University Rankings, forcing National University of Singapore into second place.